Cripto-1 modulates macrophage cytokine secretion and phagocytic activity via NF-κB signaling

Immunol Res. 2016 Feb;64(1):104-14. doi: 10.1007/s12026-015-8724-3.

Abstract

Cripto-1 is an oncogenic protein belonging to the epidermal growth factor–Cripto-1/FRL-1/Cryptic family. It has important roles in tumor formation and metastasis, but its effects on the immune system are unclear. In the present study, we investigated the effects of Cripto-1 overexpression on macrophage activities and examined the underlying mechanisms. A cell line stably overexpressing Cripto-1 was developed. The culture supernatant from this cell line was collected and used to condition macrophages (RAW264.7, THP-1, and primary mouse macrophages) for various times. Exposure to this supernatant significantly increased the mRNA and protein expression levels of the anti-inflammatory cytokine interleukin (IL)-10 and of three pro-inflammatory cytokines (tumor necrosis factor-α, IL-6, and IL-1β), but did not affect the expression of transforming growth factor-β, another anti-inflammatory cytokine. Exposure to this supernatant also enhanced macrophage phagocytosis of chicken erythrocytes and yeast cells. Similar effects were observed in macrophages stimulated with purified Cripto-1 protein. Mechanistic experiments revealed that Cripto-1 activated nuclear factor (NF)-κB signaling by inducing IκB kinase phosphorylation and p65 nuclear translocation. Pretreatment with ammonium pyrrolidine dithiocarbamate, a specific NF-κB inhibitor, inhibited Cripto-1-induced cytokine secretion and phagocytosis of macrophages. Taken together, our present findings suggest that Cripto-1 enhances macrophage phagocytic activity and upregulates the production of anti- and pro-inflammatory cytokines via the NF-κB signaling pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Cytokines / genetics
  • Cytokines / metabolism
  • GPI-Linked Proteins / genetics
  • GPI-Linked Proteins / metabolism*
  • Gene Expression Regulation / immunology
  • Humans
  • Inflammation Mediators / metabolism
  • Intercellular Signaling Peptides and Proteins / genetics
  • Intercellular Signaling Peptides and Proteins / metabolism*
  • Macrophage Activation* / drug effects
  • Macrophages / drug effects
  • Macrophages / immunology*
  • Mice
  • NF-kappa B / antagonists & inhibitors
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / metabolism*
  • Phagocytosis* / drug effects
  • Phagocytosis* / immunology
  • Pyrrolidines / pharmacology
  • Signal Transduction* / drug effects
  • Thiocarbamates / pharmacology

Substances

  • Cytokines
  • GPI-Linked Proteins
  • Inflammation Mediators
  • Intercellular Signaling Peptides and Proteins
  • NF-kappa B
  • Neoplasm Proteins
  • Pyrrolidines
  • TDGF1 protein, human
  • Thiocarbamates
  • pyrrolidine dithiocarbamic acid